PortfoliosLab logoPortfoliosLab logo
CLDX vs. UFPT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLDX vs. UFPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celldex Therapeutics, Inc. (CLDX) and UFP Technologies, Inc. (UFPT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLDX achieves a 40.13% return, which is significantly higher than UFPT's 14.75% return. Over the past 10 years, CLDX has underperformed UFPT with an annualized return of -5.67%, while UFPT has yielded a comparatively higher 26.61% annualized return.


CLDX

1D
-1.10%
1M
-0.81%
6M
54.72%
YTD
40.13%
1Y
71.52%
3Y*
3.07%
5Y*
-2.75%
10Y*
-5.67%
ALL TIME*
-5.66%

UFPT

1D
-0.10%
1M
-6.45%
6M
1.45%
YTD
14.75%
1Y
12.45%
3Y*
10.00%
5Y*
33.64%
10Y*
26.61%
ALL TIME*
12.48%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$36.64M$35.57M$33.98M
$43.21M$52.84M$50.76M

CLDX vs. UFPT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CLDX
Celldex Therapeutics, Inc.
40.13%7.48%-36.28%-11.02%15.35%120.55%685.65%-24.88%-93.03%-19.77%
UFPT
UFP Technologies, Inc.
14.75%-9.19%42.12%45.93%67.79%50.77%-6.07%65.15%8.06%9.23%

Correlation

The correlation between CLDX and UFPT is 0.13, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.13

Correlation (3Y)
Balances recent behavior with more history.

0.25

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.27

Correlation (10Y)
Provides a long-term view across more market conditions.

0.22

Correlation (All Time)
Calculated using the full available price history since Mar 10, 2008

0.21

The correlation between CLDX and UFPT shifts across timeframes, from 0.13 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CLDX:

$2.53B

UFPT:

$1.97B

EPS

CLDX:

-$4.27

UFPT:

$8.80

PS Ratio

CLDX:

3.09K

UFPT:

3.26

PB Ratio

CLDX:

5.55

UFPT:

4.53

Total Revenue (TTM)

CLDX:

$820.00K

UFPT:

$608.85M

Gross Profit (TTM)

CLDX:

$805.00K

UFPT:

$172.62M

EBITDA (TTM)

CLDX:

-$216.32M

UFPT:

$111.39M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CLDX vs. UFPT — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CLDX
CLDX Risk / Return Rank: 8383
Overall Rank
CLDX Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
CLDX Sortino Ratio Rank: 8282
Sortino Ratio Rank
CLDX Omega Ratio Rank: 7979
Omega Ratio Rank
CLDX Calmar Ratio Rank: 8787
Calmar Ratio Rank
CLDX Martin Ratio Rank: 8787
Martin Ratio Rank

UFPT
UFPT Risk / Return Rank: 5454
Overall Rank
UFPT Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
UFPT Sortino Ratio Rank: 5252
Sortino Ratio Rank
UFPT Omega Ratio Rank: 5252
Omega Ratio Rank
UFPT Calmar Ratio Rank: 5555
Calmar Ratio Rank
UFPT Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CLDX vs. UFPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celldex Therapeutics, Inc. (CLDX) and UFP Technologies, Inc. (UFPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CLDXUFPTDifference
Sharpe ratioReturn per unit of total volatility

+1.03

Sortino ratioReturn per unit of downside risk

+1.44

Omega ratioGain probability vs. loss probability

1.26

1.09

+0.17

Calmar ratioReturn relative to maximum drawdown

3.04

0.41

+2.62

Martin ratioReturn relative to average drawdown

7.81

0.80

+7.01

CLDX vs. UFPT - Sharpe Ratio Comparison

The current CLDX Sharpe Ratio is 1.31, which is higher than the UFPT Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of CLDX and UFPT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CLDX vs. UFPT - Drawdown Comparison

The maximum CLDX drawdown since its inception was -99.73%, which is greater than UFPT's maximum drawdown of -88.53%. Use the drawdown chart below to compare losses from any high point for CLDX and UFPT.


Loading charts...

Drawdown Indicators


CLDXUFPTDifference

Max Drawdown

Largest peak-to-trough decline

-99.73%

-88.53%

-11.20%

Max Drawdown (1Y)

Largest decline over 1 year

-24.23%

-30.69%

+6.46%

Max Drawdown (3Y)

Largest decline over 3 years

-70.84%

-48.31%

-22.53%

Max Drawdown (5Y)

Largest decline over 5 years

-73.11%

-48.31%

-24.80%

Max Drawdown (10Y)

Largest decline over 10 years

-97.90%

-48.31%

-49.59%

Current Drawdown

Current decline from peak

-93.29%

-28.92%

-64.37%

Average Drawdown

Average peak-to-trough decline

-78.14%

-32.24%

-45.90%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.40%

15.78%

-6.38%

Volatility

CLDX vs. UFPT - Volatility Comparison

The current volatility for Celldex Therapeutics, Inc. (CLDX) is 13.11%, while UFP Technologies, Inc. (UFPT) has a volatility of 15.03%. This indicates that CLDX experiences smaller price fluctuations and is considered to be less risky than UFPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLDXUFPTDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.11%

15.03%

-1.92%

Volatility (6M)

Calculated over the trailing 6-month period

37.30%

32.45%

+4.85%

Volatility (1Y)

Calculated over the trailing 1-year period

56.28%

44.60%

+11.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.29%

44.69%

+12.60%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.91%

39.75%

+38.16%

Dividends

CLDX vs. UFPT - Dividend Comparison

Neither CLDX nor UFPT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLDX vs. UFPT - Financials Comparison

This section allows you to compare key financial metrics between Celldex Therapeutics, Inc. and UFP Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


CLDX and UFPT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UFPT has higher volatility (15.03%) compared to CLDX (13.11%). In terms of maximum drawdown, CLDX dropped -99.73% vs UFPT's -88.53%.

CLDX currently has the higher Sharpe Ratio (1.31 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLDX and UFPT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer